2002 Quarterly Earnings Reports
Biotechnology Sector Companies
Updated 11/10/04
Current publicly reported financial results (in $millions) for biotechnology-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Advanced Tissue Sciences (ATIS) | $4.7 | ($7.7) | $6.2 | ($8.6) | $5.0 | ($10.4) | $15.9 | ($26.7) | ||
| Amgen (AMGN) | $1,008.5 | $340.9 | $1,249.1 | $412.4 | $1,499.3 | ($2,601.6) | $1,776.1 | $456.4 | $5,533.0 | ($1,391.9) |
| Biogen (BGEN) | $288.3 | $72.1 | $269.3 | $43.4 | $288.3 | $42.2 | $302.4 | $81.0 | $1,148.3 | $238.7 |
| Cell Genesys (CEGE) | $4.6 | ($8.8) | $31.1 | $6.5 | $1.5 | ($12.7) | $2.0 | ($12.3) | $39.1 | ($27.3) |
| Cell Pathways (CLPA) | $0.0 | ($5.6) | $0.3 | ($1.8) | $0.4 | ($4.7) | $0.4 | ($5.7) | $1.1 | ($17.8) |
| Cell Therapeutics (CTIC) | $1.7 | ($23.6) | $2.8 | ($26.5) | $4.4 | ($30.4) | $8.0 | $30.5 | $16.9 | ($49.9) |
| Chiron (CHIR) | $252.2 | ($18.9) | $299.3 | $50.4 | $368.5 | $82.2 | $356.3 | $67.1 | $1,276.3 | $180.8 |
| Corvas (CVAS) | $0.0 | ($5.2) | $0.0 | ($5.5) | $0.0 | ($6.6) | $0.0 | ($4.0) | $0.1 | ($21.2) |
| Cypress Bioscience (CYPB) | $6.4 | $4.1 | $0.0 | ($1.6) | $0.0 | ($1.8) | $0.0 | ($1.7) | $6.4 | ($1.0) |
| Dendreon (DNDN) | $3.0 | ($7.4) | $3.1 | ($6.3) | $5.0 | ($5.2) | $4.1 | ($5.8) | $15.3 | ($24.7) |
| Epimmune (EPMN) | $2.0 | ($1.1) | $1.8 | ($2.2) | $1.7 | ($1.5) | $1.6 | ($1.7) | $7.1 | ($6.5) |
| Genentech (DNA) | $568.1 | $95.3 | $622.2 | ($213.7) | $650.1 | $89.3 | $743.2 | $92.8 | $2,583.6 | $63.8 |
| Genzyme General (GENZ) | $297.9 | ($91.5) | $332.2 | $28.3 | $340.2 | $25.1 | $359.2 | $25.1 | $1,329.5 | ($13.0) |
| Genzyme Biosurgery (GZBX) | $53.4 | ($116.2) | $62.9 | ($15.1) | $65.1 | ($22.1) | $58.8 | ($14.6) | $240.1 | ($167.9) |
| Genzyme Molecular (GZMO) | $2.4 | ($6.0) | $2.4 | ($6.2) | $2.3 | ($6.3) | $2.3 | ($5.1) | $9.3 | ($23.7) |
| Nuvelo (NUVO) | $5.2 | ($19.0) | $6.7 | ($8.1) | $11.0 | ($1.4) | $3.5 | ($16.5) | $26.4 | ($45.0) |
| Icos (ICOS) | $22.5 | ($39.2) | $22.0 | ($40.4) | $22.2 | ($32.5) | $26.2 | ($47.5) | $92.9 | ($161.6) |
| IDEC | $79.7 | $29.7 | $97.1 | $35.4 | $103.7 | $38.4 | $123.7 | $44.6 | $404.2 | $148.1 |
| Immucell (ICCC) | $1.9 | $0.2 | $1.6 | $0.0 | $1.4 | $0.0 | $1.4 | $0.7 | $6.3 | $0.9 |
| Immune Response (IMNR) | $0.0 | ($5.2) | $0.0 | ($8.1) | $0.0 | ($5.5) | $0.03 | ($12.0) | $0.05 | ($30.8) |
| MedImmune (MEDI) | $329.6 | ($1,116.9) | $63.7 | ($29.5) | $74.2 | ($36.3) | $385.2 | $84.6 | $852.70 | ($1,098.1) |
| Nanogen (NGEN) | $1.5 | ($7.5) | $2.0 | ($8.5) | $1.6 | ($8.2) | $12.1 | $2.0 | $17.1 | ($22.2) |
| Onyx Pharmaceuticals (ONXX) | $0.8 | ($9.8) | $0.7 | ($11.9) | $1.2 | ($10.8) | $0.0 | ($13.3) | $2.7 | ($45.8) |
| Protein Design Labs (PDLI) | $14.3 | $1.8 | $14.8 | ($0.6) | $6.5 | ($8.0) | $10.7 | ($7.9) | $46.4 | ($14.6) |
| Regeneron (RGEN) | $4.9 | ($25.4) | $5.6 | ($30.4) | $6.6 | ($32.8) | $4.9 | ($35.7) | $21.9 | ($124.3) |
| Sirna Therapeutics (RNAI) | $1.6 | ($8.5) | $1.6 | ($9.6) | $1.3 | ($7.3) | $0.6 | ($10.9) | $5.2 | ($34.7) |
| Viragen (VRA) | $0.4 | ($3.1) | $0.4 | ($2.4) | $0.3 | ($3.0) | $0.1 | ($4.1) | $1.2 | ($12.6) |
| TOTALS | $2,747.0 | ($1,024.9) | $2,926.6 | $131.6 | $3,277.2 | ($2,577.7) | $4,004.2 | $649.6 | $12,955.0 | ($2,819.8) |
